Late onset asthma: Epidemiology, diagnosis and treatment

Drugs and Aging

Volumn 17, Issue 5, 2000, Pages 385-397

  Kitch, Barrett T ^a,b   Levy, Bruce D ^b   Fanta, Christopher H ^b  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ALLOPURINOL; BECLOMETASONE; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; BRONCHODILATING AGENT; BUDESONIDE; CIMETIDINE; CORTICOSTEROID; CROMOGLYCATE DISODIUM; FLUNISOLIDE; FLUTICASONE PROPIONATE; IMMUNOGLOBULIN E; IPRATROPIUM BROMIDE; LEUKOTRIENE MODIFIER; MACROLIDE; MONOAMINE OXIDASE INHIBITOR; MONTELUKAST; NEDOCROMIL; ORAL CONTRACEPTIVE AGENT; PIRBUTEROL; PROPRANOLOL; QUINOLONE DERIVATIVE; SALBUTAMOL; THEOPHYLLINE; TIMOLOL; TRIAMCINOLONE; TROLEANDOMYCIN; UNCLASSIFIED DRUG; UNINDEXED DRUG; ZAFIRLUKAST; ZILEUTON;

ASTHMA; CATARACT; CLINICAL TRIAL; DIFFERENTIAL DIAGNOSIS; FORCED EXPIRATORY VOLUME; HUMAN; HUMAN CELL; HUMAN TISSUE; INTRAOCULAR PRESSURE ABNORMALITY; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REVIEW; SMOKING CESSATION;

AGE OF ONSET; AGED; ASTHMA; GERIATRICS; HUMANS;

EID: 0033661832     PISSN: 1170229X     EISSN: None     Source Type: Journal    
DOI: 10.2165/00002512-200017050-00005     Document Type: Review

References (78)

1. Underdiagnosis and undertreatment of asthma in the elderly
2. A community-based study of the epidemiology of asthma: Incidence rates, 1964-1983
3. Characteristics of asthma among elderly adults in a sample of the general population
4. Quality of life in elderly subjects with a diagnostic label of asthma from general practice registers
5. Underdiagnosis of asthma in the elderly
6. The interaction between immunoglobin E and smoking in airflow obstruction in the elderly
7. Findings before diagnosis of asthma among the elderly in a longitudinal study of a general population study
8. Asthma in the elderly: An epidemiologic survey
9. Predictors of the new onset of wheezing among middle aged and older men: The Normative Aging Study
10. The natural history of asthma in adults: The problem of irreversibility
11. The prevalence and incidence of asthma and asthma-like symptoms in a general population sample
12. The epidemiology of asthma and hay fever in a total community, Tecumseh, Michigan: I. Description of study and general findings
13. Incidence and outcomes of asthma in the elderly: A population-based study in Rochester, Minnesota
14. Increases in deaths from asthma
15. Changing asthma mortality
16. Changing patterns of asthma mortality: Identifying target populations at high risk
17. Further investigation into the recent increase in asthma death rates: A review of 41 asthma deaths in Oregon in 1982
18. Pathology of asthma in the elderly
19. Smoking, atopy, and methacholine airway responsiveness among middle-aged and elderly men: The Normative Aging Study
20. Effect of age on bronchodilator response
21. Exposure to house-dust mite allergen (Der p I) and the development of asthma in childhood: A prospective study
22. Epidemiology and natural history
23. Is asthma in the elderly really different?
24. Asthma in the elderly: A comparison between patients with recently acquired and long-standing disease
25. Intrinsic asthma
26. Nonspecific bronchial reactivity in occupational asthma
27. Occupational asthma
28. Occupational asthma
29. A prospective study of asthma in a rural community
30. Rate of decline of lung function in subjects with asthma
31. Seven year follow-up study of 343 adults with bronchial asthma
32. The course and prognosis of different forms of chronic airways obstruction in a sample from the general population
33. The role of allergy and airway inflammation
34. Breathing better or wheezing worse? The changing epidemiology of asthma morbidity and mortality
35. Asthma, United States, 1982-1992
36. An audit of morbidity associated with chronic asthma in a general practice
37. Standardization of spirometry, 1994 update
38. Characteristics of asthma in the elderly
39. Comparisons of asthma, emphysema, and chronic bronchitis diagnosis in a general population sample
40. Respiratory illness, beta-agonists, and risk of idiopathic dilated cardiomyopathy: The Washington, DC, Dilated Cardiomyopathy Study
41. Immediate skin-test reactivity in a general population sample
42. An assessment of methacholine inhalation tests in elderly asthmatics
43. The effect of age on methacholine responsiveness
44. A controlled trial of sustained-release bupropion, a nicotine patch, or both for smoking cessation
45. Bupropion: A review of its use in the management of smoking cessation
46. Peripheral mononuclear leukocyte adrenoceptors and non-specific bronchial responsiveness to methacholine in young and elderly normal subjects and asthmatic patients
47. Influence of age on response to ipratropium and salbutamol in asthma
48. Bronchodilator responses to salbutamol followed by ipratropium bromide in partially reversible airflow obstruction
49. Tachyphylaxis to systemic but not to airway responses during prolonged therapy with high dose inhaled salbutamol in asthmatics
50. Dose response to ipratropium as a nebulized solution in patients with chronic obstructive pulmonary disease
51. Effect of long-term treatment with inhaled budesonide in patients with mild chronic obstructive pulmonary disease who continue smoking
52. Long-term effect of inhaled budesonide in mild and moderate chronic obstructive pulmonary disease: A randomised controlled trial
53. Inhaled and nasal glucocorticoids and the risks of ocular hypertension or open-angle glaucoma
54. Dose-related decrease in bone density among asthmatic patients treated with inhaled corticosteroids
55. Use of inhaled corticosteroids and the risk of cataracts
56. Absence of posterior subcapsular cataracts in young patients treated with inhaled glucocorticoids
57. Posterior subcapsular cataract and inhaled corticosteroid therapy
58. Association of ocular cataracts with inhaled and oral steroid therapy during long-term treatment of asthma
59. Theophylline in asthma
60. The influence of age vs. peak serum concentration on life-threatening events after chronic theophylline intoxication
61. Added salmeterol versus higher-dose corticosteroid in asthma patients with symptoms on existing inhaled corticosteroid
62. Nedocromil sodium: A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in the treatment of reversible obstructive airways disease
63. Treatment of asthma with drugs modifying the leukotriene pathway
64. Effect of treatment with zileuton, a 5-lipoxygenase inhibitor, in patients with asthma: A randomized controlled trial
65. Pulmonary infiltrates, eosinophilia, and cardiomyopathy following corticosteroid withdrawal in pateints with asthma receiving zafirlukast
66. Churg-Strauss syndrome in patients receiving montelukast as treatment for asthma
67. Zafirlukast: A review of its pharmacology and therapeutic potential
68. Effect of montelukast on the pharmacokinetics and pharmacodynamics of warlatin in healthy volunteers
69. Clinical relevance of pharmacokinetic differences between beta blockers
70. Timotol eyedrop-induced fatal bronchospasm in an asthmatic patient
71. Putative mechanism of cough after treatment with angiotensin-converting enzyme inhibitors
72. A comparison of breath-actuated and conventional metered-dose inhaler inhalation techniques in elderly subjects
73. Improvement of pressurized aerosol deposition with nebuhaler spacer device
74. Improvement of drug delivery with a breath actuated pressurized aerosol for patients with poor inhaler technique